Solution
Industries
Resources
About

Global Markets for In Vitro Toxicity Testing

Report Code: PHM017D

Publish Date: Sep 2010

Publisher: BCC Publishing

Category: Pharmaceuticals

Customize This Report

Explore Our Services

Already a member? Login to access this report free.

Report Highlights

  • The global in vitro toxicity (predictive toxicity) testing market is valued at more than $1.3 billion in 2010.  With heightened awareness of animal welfare in laboratory research testing, the in vitro toxicity testing market has an anticipated value of $2.7 billion in 2015, a compound annual growth rate (CAGR) of 15% between 2010 and 2015.
  • The largest market sector is currently the cosmetics and personal-care industry, which accounts for a market share of more than 50%. This sector is currently valued at $702 million and is expected to reach $1.3 billion by 2015, a compound annual growth rate (CAGR) of 13.1%.
  • The pharmaceuticals segment is one of the most significant with a 32% market share valued at $424 million in 2010. By 2015, this sector is projected to reach a value of $976 million, a compound annual growth rate (CAGR) of 18.2%.

INTRODUCTION

STUDY GOALS AND OBJECTIVES
 
BCC’s goal in conducting this study was to determine the current status of the global in vitro toxicity testing market and assess its growth potential over the 5-year period from 2010 to 2015. We were particularly interested in understanding the current market scenario for alternative measures to animal testing.
 
Predictive toxicology is often cross-referenced with in vitro methods. This report assesses the growth and market potential for these methods. In addition, we were interested in understanding the impact of these methods on different industry sectors.
 
One key objective was to present an analysis of the current in vitro toxicity testing market in major national markets and its future direction.
 
REASONS FOR DOING THE STUDY
 
Classical toxicology testing programs have been in place for many decades now. Over the past 2 decades, ongoing animal welfare activities have spurred the idea of pursuing alternative testing measures in toxicity with minimal pain and suffering to animals. This report aims to identify the key advances in different test categories and the extent of validation by the regulatory authorities. We also were interested in identifying the impact of new technology advancements with possible toxicology applications and also examining their growth potential.
 
There are different industries that require toxicity testing of their products. Previously, there was broad coverage of these applications. As this market relies strongly on both technology and regulatory forces, this study was aimed to identify the relevance of current developments on pharmaceuticals, chemicals, food additives, cosmetics, and household products.
 
SCOPE OF REPORT
 
The study encompasses the major types of traditional toxicity testing methods and the in vitro techniques that have been under review of the Interagency Coordinating Committee for Validation of Alternative Methods (ICCVAM) test methods for toxicity. BCC discusses the two major technology based approaches, mechanistic and nonmechanistic, and determines current market status; examines impact on future markets; and presents forecasts of growth over the next 5 years. Technological issues, including the latest trends, are discussed. Other influential factors such as validation of these alternative measures for toxicity and toxicity testing strategies for chemicals, pesticides, and food additives have also been included. BCC also examines the regulatory role and the different federal and international agencies that play an active role in in vitro toxicology research.
 
INTENDED AUDIENCE
 
This report is designed to satisfy the information needs of a wide variety of individuals involved in the toxicity marketplace, including company senior management executives seeking to base their strategic decisions on the latest insights into toxicology market forces and trends. It is also aimed at managers and executives in product research and development and particularly those responsible for bringing new products to market.
 
METHODOLOGY AND INFORMATION SOURCES
 
Both primary and secondary research methodologies were used in preparing this study. Primary research includes interviews with leading individuals in relevant companies and associations; primary sources of published data include research studies, company annual reports, and government publications. Secondary sources consist of literature searches, industry journals, and other commercial publications. Data for market estimates and forecasts are pooled from a range of sources, critically assessed by BCC.
 
ANALYST’s CREDENTIALS
 
Paul Evers has been involved in analyzing pharmaceutical markets for 20 years. He is the author of previous reports on leading-edge developments at the interface between Research and Development (R&D) and the marketplace. 
 
BCC ONLINE SERVICES
 
BCC offers an online information retrieval service. BCC’s home page, located at
www.bccresearch.com, enables readers to: 
  • Examine BCC’s complete catalog of Market Research Reports and place direct orders
  • Subscribe to any of BCC’s many industry newsletters
  • Read announcements of recently published reports and newly launched newsletters
  • Register for BCC’s well-known conferences
  • Request additional information on any BCC product
  • Take advantage of special offers.
DISCLAIMER
 
The information developed in this report, is intended to be as reliable as possible at the time of publication and of a professional nature. This information does not constitute managerial, legal, or accounting advice; nor should it serve as a corporate policy guide, laboratory manual, or an endorsement of any product, as much of the information is of a speculative in nature.  The author assumes no responsibility for any loss or damage that might result from reliance on the reported information or from its use.
Need pricing for multiple titles, a complete report bundle, or something specially curated to fit your budget? EXPLORE OFFERS
Let us assist you! Our analysts are ready to tailor this report to your specific need. Talk to Our Analyst

Table of Contents

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
[+] Show Chapter Details
Title/Chapter NamePagesMember Price
Full Report: Global Markets for In Vitro Toxicity Testing154Free
Chapter- 1: INTRODUCTION3Free
Chapter- 2: SUMMARY3Free
Chapter- 3: OVERVIEW4Free
Chapter- 4: TOXICOLOGY BACKGROUND33Free
Chapter- 5: IN VITRO TOXICOLOGY 64Free
Chapter- 6: COMMERCIAL ASPECTS 19Free
Chapter- 7: THE TOXICOLOGY INDUSTRY 26Free
Chapter- 8: APPENDIX2Free

Related Reports

Track the Latest Global Tariff Developments

In today's fast-paced global economy, tariffs are no longer static—they are dynamic levers shaped by geopolitical realignments, supply chain vulnerabilities, inflationary pressures, and sustainability-driven trade reforms. As governments worldwide recalibrate their trade strategies, businesses are left to navigate a maze of shifting rules, rising costs, and regulatory uncertainty.

Our analysis empowers you with real-time updates and in-depth expert analysis on all facets of global tariff activity. From new trade agreements and sanctions to abrupt tariff hikes and retaliatory duties, we monitor developments across borders, sectors, and industries—so you don't have to.

Whether it's the ongoing U.S.–China trade dynamics, the evolving EU Carbon Border Adjustment Mechanism (CBAM), or the emerging policies in India, ASEAN, and Latin America, we provide full-spectrum coverage. We also track multilateral trade negotiations, World Trade Organization (WTO) rulings, and sector-specific duty structures—ensuring you are always ahead of global trade shifts.

With our analysis, you can stay informed, identify risks, and confidently respond to tariff changes—no matter where you operate.

Ready to see what tariff means for your business?

Consult with our experts or request your custom Tariff Impact Brife today

Stay Informed, Stay Competitive

In today's interconnected and unpredictable global economy, staying ahead of tariff shifts is not just important—it's essential. BCC Research provides decision-makers with trusted, research-driven insights that turn uncertainty into opportunity.

Our in-depth market analysis and trade intelligence help you decode how tariff changes impact your specific sector—manufacturing, healthcare, technology, agriculture, or energy. We break down complex data into actionable knowledge through comprehensive reports, expert commentaries, and sector-focused forecasts.

Our analysis includes:

  • Thorough breakdowns of current and proposed tariff policies and how they affect regional and global trade flows.
  • Sector-specific implications, helping you understand the strategic impact on sourcing, pricing, and competitiveness.
  • Forward-looking insights to support risk management, planning, and response strategies for evolving trade conditions.

With BCC Research, you gain more than just information—you gain clarity and confidence to make well-informed decisions in a volatile trade environment.

Don't let tariffs catch you off guard—let our insights guide your strategy.

This is an Excel-only version of the report.

Report Includes

    Total Number of Tables in this Report: 23

  • Summary Table: GLOBAL IN VITRO TOXICOLOGY MARKET, THROUGH 2015
  • Table 1: APPROXIMATE RAT ORAL LD50 FOR VARIOUS CHEMICAL SUBSTANCES
  • Table 2: RISK ASSESSMENT BASED ON TOXICITY STUDIES
  • Table 3: DRAIZE TEST CLASSIFICATION OF DERMAL IRRITATION POTENTIAL
  • Table 4: EVOLUTION OF IN VITRO TOXICOLOGY
  • Table 5: REGULATORY AND SCIENTIFIC ORGANISATIONS INVOLVED IN DEVELOPMENT OF ALTERNATIVE TESTING METHODS
  • Table 6: VALIDATION AND REGULATORY ACCEPTANCE STATUS OF ALTERNATIVE TEST METHODS AND TESTING STRATEGIES
  • Table 7: IN VITRO TOXICITY TESTING MARKET BY INDUSTRY SECTOR, THROUGH 2015
  • Table 8: WORLD IN VITRO TOXICOLOGY MARKET, THROUGH 2015
  • Table 9: U.S. IN VITRO TOXICOLOGY MARKET, THROUGH 2015
  • Table 10: COMPANIES IN THE U.S. IN VITRO TOXICITY MARKETPLACE
Sample Report

Recent Reports

Clinical Nutrition: Global Markets to 2031

Published - Jun 2026 | Publisher - BCC Publishing | Code - PHM198C

The global market for clinical nutrition is expected to grow from $79.5 billion in 2026 and is projected to reach $104.7 billion by the end of 2031, at a compound annual growth rate (CAGR) of 5.6% during the forecast period of 2026 to 2031.

Substance Use Disorder Treatment: Global Markets to 2030

Published - Jun 2026 | Publisher - BCC Publishing | Code - PHM035D

The global substance use disorder (SUD) treatment market was valued at $11.6 billion in 2025, and it is expected to reach $14.6 billion by the end of 2030, at a compound annual growth rate (CAGR) of 4.6% from 2025 to 2030.

In Vitro Toxicity Testing: Technologies and Global Markets

Published - May 2026 | Publisher - BCC Publishing | Code - PHM017H

The global in vitro toxicity testing market was valued at $17.4 billion in 2025 and is projected to reach $28 billion by the end of 2030, at a compound annual growth rate of 10% from 2025 to 2030.

Cardiovascular Drugs: Global Markets to 2030

Published - Apr 2026 | Publisher - BCC Publishing | Code - PHM191B

The global market for cardiovascular drugs was valued at $183.7 billion in 2025 and is estimated to reach $228.6 billion by 2030, at a compound annual growth rate (CAGR) of 4.5% from 2025 through 2030.

Emerging Drugs: Global Markets

Published - Apr 2026 | Publisher - BCC Publishing | Code - PHM291A

The report provides an overview of the global emerging drugs and analyzes market trends, segmented by molecule type, product type, therapeutic application, and end user. It includes global revenue for the base year of 2024 and estimated data for the forecast period 2025 through 2030. The report focuses on trends, challenges, and the competitive landscape, including market share of leading companies and company profiles with financials, product portfolios, and recent developments.

Top Trending Reports

2025 Medical Devices Research Review

Published - Apr 2026 | Publisher - BCC Publishing | Code - MDS060C

Get a concise view of the medical devices sector with BCC Research’s 2025 review covering market dynamics, emerging technologies and industry developments.

Cancer Profiling and Pathways: Technologies and Global Markets

Published - May 2026 | Publisher - BCC Publishing | Code - BIO073D

The global market for cancer profiling and pathway technologies is expected to grow from $18.3 billion in 2025 and is projected to reach $33.9 billion by the end of 2030, at a compound annual growth rate (CAGR) of 13.2% during the forecast period of 2025 to 2030.

Validation, Calibration, and Standardization in the Life Sciences Market

Published - Mar 2026 | Publisher - BCC Publishing | Code - BIO179B

The global market for validation, calibration, and standardization in life sciences was valued at $2.8 billion in 2025 and is estimated to reach $3.9 billion by 2030, at a compound annual growth rate (CAGR) of 6.7% from 2025 through 2030.

Glass Fiber: Global Markets

Published - May 2026 | Publisher - BCC Publishing | Code - AVM225B

The global market for glass fiber is expected to grow from $13.5 billion in 2026 and is projected to reach $17.2 billion by the end of 2031, at a compound annual growth rate (CAGR) of 4.9% during the forecast period of 2026 to 2031.

2025 Chemical Research Review

Published - Apr 2026 | Publisher - BCC Publishing | Code - CHM190B

BCC Research’s 2025 Chemical Research Review covering market trends, specialty chemicals, industrial innovation and growth opportunities across the chemical industry.

Published - Mar-2007| Analyst - Vanita Khetan| Code - PHM017C

Report Highlights

  • The U.S. in vitro toxicity (predictive toxicity) testing market has been valued at $765 million in 2006. At a compound annual growth rate (CAGR) of 14.4%, the total U.S. market will grow to reach $1.5 billion by 2011.
  • Mechanistic toxicology testing had the highest growth through the forecast period, with an estimated CAGR of 21.8%. This sector of the market will be worth $720 million by 2011.
  • Non-mechanistic toxicology testing was the larger of the two sectors in 2006. Even with a CAGR of 9.4%, it will still maintain the majority of the market at $780 million in 2011.
Published - Jun-2003| Analyst - Sam Brauer| Code - PHM017B

Report Highlights

  • The pharmaceutical industry accounts for more than 90% of the industry.
  • In vitro toxicology growth (12.4%/year) will be higher than pharmaceutical R& D.
  • The pharmaceutical market will reach about $18.58 billion by 2007.
  • All other markets will grow 8%/year to reach $103 milion.
  • Overall, in vitro toxicology markets will see an AAGR of 12.1%.

Become A Member

BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.

Find Out More

Custom Consulting

BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.

Customize Now

Scorecard

The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.

Find Out More

Innovation Spotlight

Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.

Find Out More
Global Markets for In Vitro Toxicity Testing
Customize This Report
Customize Report
Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.
Contact
© 2026 BCC Research
Privacy Policy |Site Map|Terms & Conditions
AI Sentiment